News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Cubist Pharmaceuticals, Inc. 2Q10 Total Net Revenues Up 29% to $168.5 Million
July 16, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Collaboration
Astellas Keeps Chinese Collab Train Chugging With $1.5B+ Bet for Claudin ADC
May 30, 2025
·
2 min read
·
Tristan Manalac
Layoffs
After Safety Stumbles, Keros Axes Pulmonary Hypertension Drug, 45% of Staff
May 30, 2025
·
2 min read
·
Tristan Manalac
Company closure
iTeos To Close Down After TIGIT Fail
May 29, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs
May 28, 2025
·
2 min read
·
Annalee Armstrong
